The worlds of pain management, medical cannabis and psychedelics are intersecting, so what does this ultimately mean?
Dr. Hance Clarke, Director of Pain Services and Medical Director of the Pain Research Unit at the Toronto General Hospital, joins Kenrick to break it all down. They discuss macro trends in the public markets, cannabis, new Healthcare IT for patient care, and risk factors associated with continued opioid use and after major surgery.
Guest speaker - Hance Clarke
Dr. Clarke is the director of Pain Services and the medical director of the Pain Research Unit at the Toronto General Hospital. He is appointed to the Institute of Medical Sciences at the University of Toronto and is a graduate of the Royal College Clinician Scientist Program. His research interests include identifying novel acute pain treatments following major surgery, identifying the factors involved in the transition of acute postsurgical pain to chronic pain, studying the genetics of acute and chronic pain after surgery, and identifying risk factors associated with continued opioid use and poor health related quality of life after major surgery as well as the efficacy of hyperbaric medicine. Over the past five years he has authored 47 peer reviewed manuscripts.